XML 67 R29.htm IDEA: XBRL DOCUMENT
v3.25.3

Discontinued operations | 12 Months Ended
--- | ---
Sep. 30, 2025
Discontinued Operations and Disposal Groups [Abstract] |
Discontinued operations | Note 19 – Discontinued operations On August 11, 2025, the Company’s wholly-owned subsidiary, SRx Health Solutions Inc. (“Health Solutions” or the “Discontinued Operations”), filed for protection under the Companies’ Creditors Arrangement Act (“CCAA”). As a result, the Health Solutions segment has been classified as discontinued operations for all periods presented. The financial statements for the years ended September 30, 2025 and 2024 reflect only continuing operations, and results of the discontinued Health Solutions segment are presented separately in this footnote. Results of Operations of Discontinued Operations The results of operations for the Health Solutions segment included in discontinued operations are as follows (in thousands): Schedule of operations of discontinued operations
|  |  | 2025 |  |  |  | 2024 |
|  |  | Year ended September 30, |
|  |  | 2025 |  |  |  | 2024 |
Net sales |  | $ | 39,364 |  |  | $ | 145,242 |
Cost of sales |  |  | 30,462 |  |  |  | 120,908 |
Income tax expense (benefit) |  |  | 357 |  |  |  | (900 | )
Net loss from discontinued operations |  |  | (36,367 | ) |  |  | (43,054 | )
Cash Flows of Discontinued Operations The cash flows attributable to the Health Solutions segment are summarized as follows (in thousands): Schedule of cash flow of discontinued operations
|  |  | 2025 |  |  |  | 2024 |
|  | Year Ended September 30, |
|  | 2025 |  |  | 2024 |
Cash flows (used in) provided by: |  |  |  |  |  |  |  |
Operating activities |  | $ | (2,791 | ) |  | $ | (1,724 | )
Investing activities |  |  | 4,915 |  |  |  | (1,113 | )
Financing activities |  |  | (10,647 | ) |  |  | 863 |
Net decrease in cash and cash equivalents |  | $ | (8,523 | ) |  | $ | (1,974 | )
Notes and Additional Information All prior period results for Health Solutions, including the year ended September 30, 2024, are presented within discontinued operations. All historical acquisitions associated with the Health Solutions segment relate solely to the discontinued business and were fully deconsolidated in connection with the CCAA process; accordingly, no ASC 805 business combination disclosures are included within the Company’s continuing operations. The financial impact of Health Solutions’ filing under CCAA is reflected in the measurement of net assets and any associated impairment or restructuring charges, if applicable. Refer to Note 10 – Commitments and contingencies for additional details related to obligations of the discontinued operations. The Company was subject to certain financial covenants under its senior secured term facilities with Canadian Western Bank (“CWB”) related to SRx Canada. As of the date of CCAA filing and subsequent disposal of the business, the Company was not in compliance with these covenants. The debt associated with these facilities has been deconsolidated from the Company’s financial statements. The underlying obligations, however, will not be legally settled or extinguished until completion of the CCAA process. Subsequent to September 30, 2025, the Company entered into a Settlement, Share Forfeiture and Mutual Release Agreement with certain former founders and officers of SRx Canada, resulting in the forfeiture and cancellation of 18,839,332 shares of SRx Canada stock, of which 376,121 were common shares of the Company. The remaining shares were exchangeable into Company common stock on a one-for-one basis. This transaction has been reflected in the post-closing adjustments to the discontinued operations results.

X
- References No definition available. + Details
Name: | us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/205-20/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/360/tableOfContent + Details
Name: | us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration